Pharmabiz

Ethiopian delegation meets DCGI and IPC to strengthen regulatory frameworks

Ethiopian delegation meets DCGI and IPC to strengthen regulatory frameworks: Shardul Nautiyal, Mumbai Tuesday, November 18, ...
Pharmabiz

Karnataka minister MB Patil chairs high-level roundtable on pharma & biotech manufacturing

Karnataka minister MB Patil chairs high-level roundtable on pharma & biotech manufacturing: Our Bureau, Bengaluru Tuesday, ...
Pharmabiz

NHS Supply Chain Selects TCS to Transform Healthcare Delivery using AI & Cloud in a 5 Year Deal

Our Bureau, Bengaluru Tuesday, November 18, 2025, 17:15 Hrs [IST] ...
Pharmabiz

Windtree reports more strengthening of its istaroxime and next generation SERCA2a activator patent estate

Windtree reports more strengthening of its istaroxime and next generation SERCA2a activator patent estate: Warrington, Pennsylvania Tuesday, November 18, 2025, 18:00 Hrs [IST] Win ...
Pharmabiz

Merus and Halozyme ink collaboration and license agreement to develop subcutaneous formulation of petosemtamab

Merus and Halozyme ink collaboration and license agreement to develop subcutaneous formulation of petosemtamab: San Diego Tuesday, November 18, 2025, 17:00 Hrs [IST] Merus N.V., a ...
Pharmabiz

Telangana DCA issues 196 show cause notices to medical shops for Schedule H1 and pharmacy violations

Telangana DCA issues 196 show cause notices to medical shops for Schedule H1 and pharmacy violations: Our Bureau, Chennai Tuesday, November 18, 2025, 13:30 Hrs [IST] The Drugs Con ...
Pharmabiz

BioLineRx receives USPTO notice of allowance for key patent covering GLIX1 for treating a broad range of cancer types

BioLineRx receives USPTO notice of allowance for key patent covering GLIX1 for treating a broad range of cancer types: Tel Aviv, Israel Tuesday, November 18, 2025, 14:00 Hrs [IST] ...
Pharmabiz

Accession Therapeutics doses first patient in phase 1 trial of TROCEPT-01, a novel cancer immunotherapy

Accession Therapeutics doses first patient in phase 1 trial of TROCEPT-01, a novel cancer immunotherapy: Oxford, UK Tuesday, November 18, 2025, 13:00 Hrs [IST] Accession Therapeut ...
Pharmabiz

EMA committee recommends orphan drug designation to BioInvent’s BI-1808 to treat cutaneous T-cell lymphoma

EMA committee recommends orphan drug designation to BioInvent’s BI-1808 to treat cutaneous T-cell lymphoma: Lund, Sweden Tuesday, November 18, 2025, 11:00 Hrs [IST] BioInvent In ...
Pharmabiz

Lilly’s donanemab receives CDSCO approval to treat early symptomatic Alzheimer’s disease

Lilly’s donanemab receives CDSCO approval to treat early symptomatic Alzheimer’s disease: Our Bureau, Mumbai Tuesday, November 18, 2025, 14:15 Hrs [IST] Eli Lilly and Company ...
Pharmabiz

Narayana Nethralaya’s KIDROP leads the way in preventing infant blindness beyond Karnataka

Narayana Nethralaya’s KIDROP leads the way in preventing infant blindness beyond Karnataka: Our Bureau, Bengaluru Tuesday, November 18, 2025, 14:40 Hrs [IST] Narayana Nethralaya ...
Pharmabiz

Zydus and SIG sign deal for novel packaging solution to unveil first single-serve spouted pouches for liquid cough and cold medication

Our Bureau, Bengaluru Tuesday, November 18, 2025, 16:50 Hrs [IST] ...